$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine

Viruses v.11 no.10 , 2019년, pp.964 -   
Abstract

Viruses are the major causes of acute and chronic infectious diseases in the world. According to the World Health Organization, there is an urgent need for better control of viral diseases. Repurposing existing antiviral agents from one viral disease to another could play a pivotal role in this process. Here, we identified novel activities of obatoclax and emetine against herpes simplex virus type 2 (HSV-2), echovirus 1 (EV1), human metapneumovirus (HMPV) and Rift Valley fever virus (RVFV) in cell cultures. Moreover, we demonstrated novel activities of emetine against influenza A virus (FLUAV), niclosamide against HSV-2, brequinar against human immunodeficiency virus 1 (HIV-1), and homoharringtonine against EV1. Our findings may expand the spectrum of indications of these safe-in-man agents and reinforce the arsenal of available antiviral therapeutics pending the results of further in vitro and in vivo tests.

  

참고문헌 (54)

  1. 1. WHO Publishes List of Top Emerging Diseases Likely to Cause Major Epidemics wwwwhoint/medicines/ebola-treatment/WHO-list-of-top-emerging-diseases/en/ 
  2. 2. Howard, Colin R, Fletcher, Nicola F. Emerging virus diseases: can we ever expect the unexpected?. Emerging microbes & infections, vol.1, no.12, e46-.
  3. 3. James, Spencer L, Abate, Degu, Abate, Kalkidan Hassen, Abay, Solomon M, Abbafati, Cristiana, Abbasi, Nooshin, Abbastabar, Hedayat, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abdollahpour, Ibrahim, Abdulkader, Rizwan Suliankatchi, Abebe, Zegeye, Abera, Semaw F, Abil, Olifan Zewdie, Abraha, Haftom Niguse, Abu-Raddad, Laith Jamal, Abu-Rmeileh, Niveen M E, Accrombessi, Manfred Mario Kokou, Acharya, Dilaram, Acharya, Pawan, Ackerman, Ilana N, Adamu, Abdu A, Adebayo, Oladimeji M, Adekanmbi, Victor, Adetokunboh, Olatunji O, Adib, Mina G, Adsuar, Jose C, Afanvi, Kossivi Agbelenko, Afarideh, Mohsen, Afshin, Ashkan, Agarwal, Gina, Agesa, Kareha M, Aggarwal, Rakesh, Aghayan, Sargis Aghasi, Agrawal, Sutapa, Ahmadi, Alireza, Ahmadi, Mehdi, Ahmadieh, Hamid, Ahmed, Muktar Beshir, Aichour, Amani Nidhal, Aichour, Ibtihel, Aichour, Miloud Taki Eddine, Akinyemiju, Tomi, Akseer, Nadia, Al-Aly, Ziyad, Al-Eyadhy, Ayman, Al-Mekhlafi, Hesham M, Al-Raddadi. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, vol.392, no.10159, 1789-1858.
  4. 4. Kyu, Hmwe Hmwe, Abate, Degu, Abate, Kalkidan Hassen, Abay, Solomon M, Abbafati, Cristiana, Abbasi, Nooshin, Abbastabar, Hedayat, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abdollahpour, Ibrahim, Abdulkader, Rizwan Suliankatchi, Abebe, Molla, Abebe, Zegeye, Abil, Olifan Zewdie, Aboyans, Victor, Abrham, Aklilu Roba, Abu-Raddad, Laith Jamal, Abu-Rmeileh, Niveen M E, Accrombessi, Manfred Mario Kokou, Acharya, Dilaram, Acharya, Pawan, Ackerman, Ilana N, Adamu, Abdu A, Adebayo, Oladimeji M, Adekanmbi, Victor, Ademi, Zanfina, Adetokunboh, Olatunji O, Adib, Mina G, Adsuar, Jose C, Afanvi, Kossivi Agbelenko, Afarideh, Mohsen, Afshin, Ashkan, Agarwal, Gina, Agesa, Kareha M, Aggarwal, Rakesh, Aghayan, Sargis Aghasi, Agrawal, Anurag, Ahmadi, Alireza, Ahmadi, Mehdi, Ahmadieh, Hamid, Ahmed, Muktar Beshir, Ahmed, Sayem, Aichour, Amani Nidhal, Aichour, Ibtihel, Aichour, Miloud Taki Eddine, Akinyemiju, Tomi, Akseer, Nadia, Al-Aly, Ziyad, Al-Eyadhy. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, vol.392, no.10159, 1859-1922.
  5. 5. De Clercq, Erik, Li, Guangdi. Approved Antiviral Drugs over the Past 50 Years. Clinical microbiology reviews, vol.29, no.3, 695-747.
  6. 6. Bekerman, Elena, Einav, Shirit. Combating emerging viral threats. Science, vol.348, no.6232, 282-283.
  7. 7. Yuan, Shuofeng, Chu, Hin, Chan, Jasper Fuk-Woo, Ye, Zi-Wei, Wen, Lei, Yan, Bingpeng, Lai, Pok-Man, Tee, Kah-Meng, Huang, Jingjing, Chen, Dongdong, Li, Cun, Zhao, Xiaoyu, Yang, Dong, Chiu, Man Chun, Yip, Cyril, Poon, Vincent Kwok-Man, Chan, Chris Chung-Sing, Sze, Kong-Hung, Zhou, Jie, Chan, Ivy Hau-Yee, Kok, Kin-Hang, To, Kelvin Kai-Wang, Kao, Richard Yi-Tsun, Lau, Johnson Yiu-Nam, Jin, Dong-Yan, Perlman, Stanley, Yuen, Kwok-Yung. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nature communications, vol.10, no.1, 120-.
  8. 8. Check Hayden, Erika. Experimental drugs poised for use in Ebola outbreak. Nature, vol.557, no.7706, 475-476.
  9. 9. Jaishankar, Dinesh, Yakoub, Abraam M., Yadavalli, Tejabhiram, Agelidis, Alex, Thakkar, Neel, Hadigal, Satvik, Ames, Joshua, Shukla, Deepak. An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye. Science translational medicine, vol.10, no.428, eaan5861-eaan5861.
  10. 10. Schor, Stanford, Einav, Shirit. Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs. DNA and cell biology, vol.37, no.2, 63-69.
  11. 11. Debing, Yannick, Neyts, Johan, Delang, Leen. The future of antivirals: broad-spectrum inhibitors. Current opinion in infectious diseases, vol.28, no.6, 596-602.
  12. 12. Yu, Fei, Lu, Lu, Du, Lanying, Zhu, Xiaojie, Debnath, Asim K., Jiang, Shibo. Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket. Viruses, vol.5, no.1, 127-149.
  13. 13. Pushpakom, Sudeep, Iorio, Francesco, Eyers, Patrick A., Escott, K. Jane, Hopper, Shirley, Wells, Andrew, Doig, Andrew, Guilliams, Tim, Latimer, Joanna, McNamee, Christine, Norris, Alan, Sanseau, Philippe, Cavalla, David, Pirmohamed, Munir. Drug repurposing: progress, challenges and recommendations. Nature reviews. Drug discovery, vol.18, no.1, 41-58.
  14. 14. Nishimura, Yuhei, Hara, Hideaki. Editorial: Drug Repositioning: Current Advances and Future Perspectives. Frontiers in pharmacology, vol.9, 1068-.
  15. 15. Xue, Hanqing, Li, Jie, Xie, Haozhe, Wang, Yadong. Review of Drug Repositioning Approaches and Resources. International journal of biological sciences, vol.14, no.10, 1232-1244.
  16. 16. Ianevski, Aleksandr, Andersen, Petter I., Merits, Andres, Bjørås, Magnar, Kainov, Denis. Expanding the activity spectrum of antiviral agents. Drug discovery today, vol.24, no.5, 1224-1228.
  17. 17. Bösl, Korbinian, Ianevski, Aleksandr, Than, Thoa T., Andersen, Petter I., Kuivanen, Suvi, Teppor, Mona, Zusinaite, Eva, Dumpis, Uga, Vitkauskiene, Astra, Cox, Rebecca J., Kallio-Kokko, Hannimari, Bergqvist, Anders, Tenson, Tanel, Merits, Andres, Oksenych, Valentyn, Bjørås, Magnar, Anthonsen, Marit W., Shum, David, Kaarbø, Mari, Vapalahti, Olli, Windisch, Marc P., Superti-Furga, Giulio, Snijder, Berend, Kainov, Denis, Kandasamy, Richard K.. Common Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis. Frontiers in immunology, vol.10, 2186-.
  18. 18. Ianevski, Aleksandr, Zusinaite, Eva, Kuivanen, Suvi, Strand, Mårten, Lysvand, Hilde, Teppor, Mona, Kakkola, Laura, Paavilainen, Henrik, Laajala, Mira, Kallio-Kokko, Hannimari, Valkonen, Miia, Kantele, Anu, Telling, Kaidi, Lutsar, Irja, Letjuka, Pille, Metelitsa, Natalja, Oksenych, Valentyn, Bjørås, Magnar, Nordbø, Svein Arne, Dumpis, Uga, Vitkauskiene, Astra, Öhrmalm, Christina, Bondeson, Kåre, Bergqvist, Anders, Aittokallio, Tero, Cox, Rebecca J., Evander, Magnus, Hukkanen, Veijo, Marjomaki, Varpu, Julkunen, Ilkka, Vapalahti, Olli, Tenson, Tanel, Merits, Andres, Kainov, Denis. Novel activities of safe-in-human broad-spectrum antiviral agents. Antiviral research, vol.154, 174-182.
  19. 19. Marjomäki, Varpu, Pietiäinen, Vilja, Matilainen, Heli, Upla, Paula, Ivaska, Johanna, Nissinen, Liisa, Reunanen, Hilkka, Huttunen, Pasi, Hyypiä, Timo, Heino, Jyrki. Internalization of Echovirus 1 in Caveolae. Journal of virology, vol.76, no.4, 1856-1865.
  20. 20. Habjan, Matthias, Penski, Nicola, Spiegel, Martin, Weber, Friedemann. T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. The Journal of general virology, vol.89, no.9, 2157-2166.
  21. 21. de Graaf, M., Herfst, S., Schrauwen, E.J.A., van den Hoogen, B.G., Osterhaus, A.D.M.E., Fouchier, R.A.M.. An improved plaque reduction virus neutralization assay for human metapneumovirus. Journal of virological methods, vol.143, no.2, 169-174.
  22. 22. Kittel, Christian, Sereinig, Sabine, Ferko, Boris, Stasakova, Jana, Romanova, Julia, Wolkerstorfer, Andrea, Katinger, Hermann, Egorov, Andrej. Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology, vol.324, no.1, 67-73.
  23. 23. Bulanova, Daria, Ianevski, Aleksandr, Bugai, Andrii, Akimov, Yevhen, Kuivanen, Suvi, Paavilainen, Henrik, Kakkola, Laura, Nandania, Jatin, Turunen, Laura, Ohman, Tiina, Ala-Hongisto, Hanna, Pesonen, Hanna M., Kuisma, Marika S., Honkimaa, Anni, Walton, Emma L., Oksenych, Valentyn, Lorey, Martina B., Guschin, Dmitry, Shim, Jungmin, Kim, Jinhee, Than, Thoa T., Chang, So Young, Hukkanen, Veijo, Kulesskiy, Evgeny, Marjomaki, Varpu S., Julkunen, Ilkka, Nyman, Tuula A., Matikainen, Sampsa, Saarela, Jani S., Sane, Famara, Hober, Didier, Gabriel, Gülsah, De Brabander, Jef K., Martikainen, Miika, Windisch, Marc P., Min, Ji-Young, Bruzzone, Roberto, Aittokallio, Tero, Vähä-Koskela, Markus, Vapalahti, Olli, Pulk, Arto, Velagapudi, Vidya, Kainov, Denis E.. Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins. Viruses, vol.9, no.10, 271-.
  24. 24. Denisova, Oxana V., Kakkola, Laura, Feng, Lin, Stenman, Jakob, Nagaraj, Ashwini, Lampe, Johanna, Yadav, Bhagwan, Aittokallio, Tero, Kaukinen, Pasi, Ahola, Tero, Kuivanen, Suvi, Vapalahti, Olli, Kantele, Anu, Tynell, Janne, Julkunen, Ilkka, Kallio-Kokko, Hannimari, Paavilainen, Henrik, Hukkanen, Veijo, Elliott, Richard M., De Brabander, Jef K., Saelens, Xavier, Kainov, Denis E.. Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection. The Journal of biological chemistry, vol.287, no.42, 35324-35332.
  25. 25. Kakkola, L, Denisova, O V, Tynell, J, Viiliäinen, J, Ysenbaert, T, Matos, R C, Nagaraj, A, Öhman, T, Kuivanen, S, Paavilainen, H, Feng, L, Yadav, B, Julkunen, I, Vapalahti, O, Hukkanen, V, Stenman, J, Aittokallio, T, Verschuren, E W, Ojala, P M, Nyman, T, Saelens, X, Dzeyk, K, Kainov, D E. Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice. Cell death & disease, vol.4, e742-.
  26. 26. Kuivanen, S., Bespalov, M.M., Nandania, J., Ianevski, A., Velagapudi, V., De Brabander, J.K., Kainov, D.E., Vapalahti, O.. Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism. Antiviral research, vol.139, 117-128.
  27. 27. Müller, Konstantin H, Kainov, Denis E, El Bakkouri, Karim, Saelens, Xavier, De Brabander, Jef K, Kittel, Christian, Samm, Elisabeth, Muller, Claude P. The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections : v-ATPase inhibitors for influenza treatment. British journal of pharmacology : BJP, vol.164, no.2, 344-357.
  28. 28. Müller, Konstantin H., Spoden, Gilles A., Scheffer, Konstanze D., Brunnhöfer, Regina, De Brabander, Jef K., Maier, Martin E., Florin, Luise, Muller, Claude P.. Inhibition by Cellular Vacuolar ATPase Impairs Human Papillomavirus Uncoating and Infection. Antimicrobial agents and chemotherapy, vol.58, no.5, 2905-2911.
  29. 29. Ianevski, Aleksandr, He, Liye, Aittokallio, Tero, Tang, Jing. SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics, vol.33, no.15, 2413-2415.
  30. 30. Tan, Suiyi, Li, Jin-Qing, Cheng, Hongyan, Li, Zhaofeng, Lan, Yan, Zhang, Ting-Ting, Yang, Zi-Chao, Li, Wenjuan, Qi, Tao, Qiu, Yu-Rong, Chen, Zhipeng, Li, Lin, Liu, Shu-wen. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1. The Journal of biological chemistry, vol.294, no.37, 13740-13754.
  31. 31. Field, A K, Davies, M E, DeWitt, C, Perry, H C, Liou, R, Germershausen, J, Karkas, J D, Ashton, W T, Johnston, D B, Tolman, R L. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.. Proceedings of the National Academy of Sciences of the United States of America, vol.80, no.13, 4139-4143.
  32. 32. Kim, Yu-Jin, Cubitt, Beatrice, Chen, Emily, Hull, Mitchell V., Chatterjee, Arnab K., Cai, Yingyun, Kuhn, Jens H., de la Torre, Juan C.. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors. Antiviral research, vol.169, 104558-.
  33. 33. Varghese, Finny S., Rausalu, Kai, Hakanen, Marika, Saul, Sirle, Kummerer, Beate M., Susi, Petri, Merits, Andres, Ahola, Tero. Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments. Antimicrobial agents and chemotherapy, vol.61, no.3, e02227-16-e02227-16.
  34. 34. Shen, Liang, Niu, Junwei, Wang, Chunhua, Huang, Baoying, Wang, Wenling, Zhu, Na, Deng, Yao, Wang, Huijuan, Ye, Fei, Cen, Shan, Tan, Wenjie. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. Journal of virology : JVI, vol.93, no.12, e00023-19-e00023-19.
  35. 35. MacGibeny, Margaret A., Koyuncu, Orkide O., Wirblich, Christoph, Schnell, Matthias J., Enquist, Lynn W.. Retrograde axonal transport of rabies virus is unaffected by interferon treatment but blocked by emetine locally in axons. PLoS pathogens, vol.14, no.7, e1007188-.
  36. 36. Yang, Shu, Xu, Miao, Lee, Emily M, Gorshkov, Kirill, Shiryaev, Sergey A., He, Shihua, Sun, Wei, Cheng, Yu-Shan, Hu, Xin, Tharappel, Anil Mathew, Lu, Billy, Pinto, Antonella, Farhy, Chen, Huang, Chun-Teng, Zhang, Zirui, Zhu, Wenjun, Wu, Yuying, Zhou, Yi, Song, Guang, Zhu, Heng, Shamim, Khalida, Martínez-Romero, Carles, García-Sastre, Adolfo, Preston, Richard A., Jayaweera, Dushyantha T., Huang, Ruili, Huang, Wenwei, Xia, Menghang, Simeonov, Anton, Ming, Guoli, Qiu, Xiangguo, Terskikh, Alexey V., Tang, Hengli, Song, Hongjun, Zheng, Wei. Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry. Cell discovery, vol.4, 31-.
  37. 37. Mukhopadhyay, Rupkatha, Roy, Sujayita, Venkatadri, Rajkumar, Su, Yu-Pin, Ye, Wenjuan, Barnaeva, Elena, Mathews Griner, Lesley, Southall, Noel, Hu, Xin, Wang, Amy Q., Xu, Xin, Dulcey, Andrés E., Marugan, Juan J., Ferrer, Marc, Arav-Boger, Ravit. Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus. PLoS pathogens, vol.12, no.6, e1005717-.
  38. 38. Valadão, Ana Luiza Chaves, Abreu, Celina Monteiro, Dias, Juliana Zanatta, Arantes, Pablo, Verli, Hugo, Tanuri, Amilcar, de Aguiar, Renato Santana. Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity. Molecules a journal of synthetic chemistry and natural product chemistry, vol.20, no.6, 11474-11489.
  39. 39. Khandelwal, Nitin, Chander, Yogesh, Rawat, Krishan Dutt, Riyesh, Thachamvally, Nishanth, Chikkahonnaiah, Sharma, Shalini, Jindal, Naresh, Tripathi, Bhupendra N., Barua, Sanjay, Kumar, Naveen. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants. Antiviral research, vol.144, 196-204.
  40. 40. Mazzon, Michela, Ortega-Prieto, Ana Maria, Imrie, Douglas, Luft, Christin, Hess, Lena, Czieso, Stephanie, Grove, Joe, Skelton, Jessica Katy, Farleigh, Laura, Bugert, Joachim J., Wright, Edward, Temperton, Nigel, Angell, Richard, Oxenford, Sally, Jacobs, Michael, Ketteler, Robin, Dorner, Marcus, Marsh, Mark. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry. Viruses, vol.11, no.2, 176-.
  41. 41. Hulseberg, C. E., Fénéant, L., Szymańska-de Wijs, K. M., Kessler, N. P., Nelson, E. A., Shoemaker, C. J., Schmaljohn, C. S., Polyak, S. J., White, J. M.. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses. Journal of virology : JVI, vol.93, no.8, e02185-18-e02185-18.
  42. 42. Kao, Jo-Chi, HuangFu, Wei-Chun, Tsai, Tsung-Ting, Ho, Min-Ru, Jhan, Ming-Kai, Shen, Ting-Jing, Tseng, Po-Chun, Wang, Yung-Ting, Lin, Chiou-Feng. The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. PLoS neglected tropical diseases, vol.12, no.8, e0006715-.
  43. 43. Cairns, Dana M., Boorgu, Devi Sai Sri Kavya, Levin, Michael, Kaplan, David L.. Niclosamide rescues microcephaly in a humanized in vivo model of Zika infection using human induced neural stem cells. Biology open, vol.7, no.1, bio031807-.
  44. 44. Huang, Lu, Yang, Mengtian, Yuan, Yan, Li, Xiaojuan, Kuang, Ersheng. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation. Antiviral research, vol.138, 68-78.
  45. 45. Wang, Y.M., Lu, J.W., Lin, C.C., Chin, Y.F., Wu, T.Y., Lin, L.I., Lai, Z.Z., Kuo, S.C., Ho, Y.J.. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission. Antiviral research, vol.135, 81-90.
  46. 46. Fang, Jin'e, Sun, Leqiang, Peng, Guiqing, Xu, Jia, Zhou, Rui, Cao, Shengbo, Chen, Huanchun, Song, Yunfeng. Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280. PloS one, vol.8, no.11, e78425-.
  47. 47. Jurgeit, Andreas, McDowell, Robert, Moese, Stefan, Meldrum, Eric, Schwendener, Reto, Greber, Urs F.. Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects. PLoS pathogens, vol.8, no.10, e1002976-.
  48. 48. Stachulski, Andrew V., Pidathala, Chandrakala, Row, Eleanor C., Sharma, Raman, Berry, Neil G., Lawrenson, Alexandre S., Moores, Shelley L., Iqbal, Mazhar, Bentley, Joanne, Allman, Sarah A., Edwards, Geoffrey, Helm, Alison, Hellier, Jennifer, Korba, Brent E., Semple, J. Edward, Rossignol, Jean-Francois. Thiazolides as Novel Antiviral Agents. 2. Inhibition of Hepatitis C Virus Replication. Journal of medicinal chemistry, vol.54, no.24, 8670-8680.
  49. 49. Wu, Chang-Jer, Jan, Jia-Tsrong, Chen, Chi-Min, Hsieh, Hsing-Pang, Hwang, Der-Ren, Liu, Hwan-Wun, Liu, Chiu-Yi, Huang, Hui-Wen, Chen, Su-Chin, Hong, Cheng-Fong, Lin, Ren-Kuo, Chao, Yu-Sheng, Hsu, John T. A.. Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide. Antimicrobial agents and chemotherapy, vol.48, no.7, 2693-2696.
  50. 50. Kim, Jung-Eun, Song, Yoon-Jae. Anti-varicella-zoster virus activity of cephalotaxine esters in vitro. The journal of microbiology, vol.57, no.1, 74-79.
  51. 51. Dong, Hui-Jun, Wang, Zhao-Hua, Meng, Wen, Li, Cui-Cui, Hu, Yan-Xin, Zhou, Lei, Wang, Xiao-Jia. The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo. Viruses, vol.10, no.11, 601-.
  52. 52. Cao, J., Forrest, J.C., Zhang, X.. A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs. Antiviral research, vol.114, 1-10.
  53. 53. Romero, M. R., Serrano, M. A., Efferth, T., Alvarez, M., Marin, J. J. G.. Effect of Cantharidin, Cephalotaxine and Homoharringtonine on "in vitro" Models of Hepatitis B Virus (HBV) and Bovine Viral Diarrhoea Virus (BVDV) Replication. Planta medica, vol.73, no.6, 552-558.
  54. 54. Qing, Min, Zou, Gang, Wang, Qing-Yin, Xu, Hao Ying, Dong, Hongping, Yuan, Zhiming, Shi, Pei-Yong. Characterization of Dengue Virus Resistance to Brequinar in Cell Culture. Antimicrobial agents and chemotherapy, vol.54, no.9, 3686-3695.

DOI 인용 스타일

"" 핵심어 질의응답